Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...

Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer Amphista Therapeutics appoints Antony Mattessich as Chief Executive Officer The appointment will accelerate the Company’s next phase of growth, advancing its next generation Targeted Glue™ protein...

Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins Draupnir Bio completes €12 million seed round to progress development of oral small molecule degraders of extracellular proteins MP Healthcare and EIFO join existing investors, Gilde Healthcare...

U.S. Believers Favor International Action on Climate Change, Nuclear Risk: UMD Poll COLLEGE PARK, Md., Dec. 7, 2011 (GLOBE NEWSWIRE) -- A majority of Americans professing belief in God favor cooperative international efforts to combat climate change and the spread of nuclear weapons...